世界のグアンファシン徐放錠市場インサイト・予測（～2027年）

• 英文タイトル：Global Guanfacine Extended-Release Pill Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4065 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はグアンファシン徐放錠の世界市場の現状について調査・分析し、2027年までの市場を予測しました。グアンファシン徐放錠の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（1mg /ピル、2mg /ピル）、用途別市場規模（子供不注意、子供感情的衝動）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・グアンファシン徐放錠の世界市場概要 ・メーカー別の競争状況、市場シェア ・グアンファシン徐放錠の種類別市場規模：1mg /ピル、2mg /ピル ・グアンファシン徐放錠の用途別市場規模：子供不注意、子供感情的衝動 ・北米のグアンファシン徐放錠市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのグアンファシン徐放錠市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのグアンファシン徐放錠市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のグアンファシン徐放錠市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのグアンファシン徐放錠市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：TWi Pharmaceuticals USA, Inc.、Shire Pharmaceuticals、APOTEX、TEVA Generics ・グアンファシン徐放錠のバリューチェーン・販売チャネル分析 ・グアンファシン徐放錠の世界市場動向

Guanfacine Extended-Release Pill is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.

Market Analysis and Insights: Global Guanfacine Extended-Release Pill Market
The global Guanfacine Extended-Release Pill market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Guanfacine Extended-Release Pill Scope and Segment
Guanfacine Extended-Release Pill market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Guanfacine Extended-Release Pill market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
1mg/Pill
2mg/Pill

Segment by Application
Inattention in Children
Children’s Emotional Impulse

By Company
TWi Pharmaceuticals USA, Inc.
Shire Pharmaceuticals
APOTEX
TEVA Generics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Guanfacine Extended-Release Pill Product Introduction
1.2 Market by Type
1.2.1 Global Guanfacine Extended-Release Pill Market Size Growth Rate by Type
1.2.2 1mg/Pill
1.2.3 2mg/Pill
1.3 Market by Application
1.3.1 Global Guanfacine Extended-Release Pill Market Size Growth Rate by Application
1.3.2 Inattention in Children
1.3.3 Children’s Emotional Impulse
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Guanfacine Extended-Release Pill Sales Estimates and Forecasts 2016-2027
2.2 Global Guanfacine Extended-Release Pill Revenue Estimates and Forecasts 2016-2027
2.3 Global Guanfacine Extended-Release Pill Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Guanfacine Extended-Release Pill Regions by Sales
2.4.1 Global Top Guanfacine Extended-Release Pill Regions by Sales (2016-2021)
2.4.2 Global Top Guanfacine Extended-Release Pill Regions by Sales (2022-2027)
2.5 Global Top Guanfacine Extended-Release Pill Regions by Revenue
2.5.1 Global Top Guanfacine Extended-Release Pill Regions by Revenue (2016-2021)
2.5.2 Global Top Guanfacine Extended-Release Pill Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Guanfacine Extended-Release Pill Sales by Manufacturers
3.1.1 Global Top Guanfacine Extended-Release Pill Manufacturers by Sales (2016-2021)
3.1.2 Global Top Guanfacine Extended-Release Pill Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Guanfacine Extended-Release Pill Sales in 2020
3.2 Global Guanfacine Extended-Release Pill Revenue by Manufacturers
3.2.1 Global Top Guanfacine Extended-Release Pill Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Guanfacine Extended-Release Pill Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Guanfacine Extended-Release Pill Revenue in 2020
3.3 Global Guanfacine Extended-Release Pill Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Guanfacine Extended-Release Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Guanfacine Extended-Release Pill Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Guanfacine Extended-Release Pill Sales by Type
4.1.1 Global Guanfacine Extended-Release Pill Historical Sales by Type (2016-2021)
4.1.2 Global Guanfacine Extended-Release Pill Forecasted Sales by Type (2022-2027)
4.1.3 Global Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
4.2 Global Guanfacine Extended-Release Pill Revenue by Type
4.2.1 Global Guanfacine Extended-Release Pill Historical Revenue by Type (2016-2021)
4.2.2 Global Guanfacine Extended-Release Pill Forecasted Revenue by Type (2022-2027)
4.2.3 Global Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
4.3 Global Guanfacine Extended-Release Pill Price by Type
4.3.1 Global Guanfacine Extended-Release Pill Price by Type (2016-2021)
4.3.2 Global Guanfacine Extended-Release Pill Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Guanfacine Extended-Release Pill Sales by Application
5.1.1 Global Guanfacine Extended-Release Pill Historical Sales by Application (2016-2021)
5.1.2 Global Guanfacine Extended-Release Pill Forecasted Sales by Application (2022-2027)
5.1.3 Global Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
5.2 Global Guanfacine Extended-Release Pill Revenue by Application
5.2.1 Global Guanfacine Extended-Release Pill Historical Revenue by Application (2016-2021)
5.2.2 Global Guanfacine Extended-Release Pill Forecasted Revenue by Application (2022-2027)
5.2.3 Global Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
5.3 Global Guanfacine Extended-Release Pill Price by Application
5.3.1 Global Guanfacine Extended-Release Pill Price by Application (2016-2021)
5.3.2 Global Guanfacine Extended-Release Pill Price Forecast by Application (2022-2027)

6 North America
6.1 North America Guanfacine Extended-Release Pill Market Size by Type
6.1.1 North America Guanfacine Extended-Release Pill Sales by Type (2016-2027)
6.1.2 North America Guanfacine Extended-Release Pill Revenue by Type (2016-2027)
6.2 North America Guanfacine Extended-Release Pill Market Size by Application
6.2.1 North America Guanfacine Extended-Release Pill Sales by Application (2016-2027)
6.2.2 North America Guanfacine Extended-Release Pill Revenue by Application (2016-2027)
6.3 North America Guanfacine Extended-Release Pill Market Size by Country
6.3.1 North America Guanfacine Extended-Release Pill Sales by Country (2016-2027)
6.3.2 North America Guanfacine Extended-Release Pill Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Guanfacine Extended-Release Pill Market Size by Type
7.1.1 Europe Guanfacine Extended-Release Pill Sales by Type (2016-2027)
7.1.2 Europe Guanfacine Extended-Release Pill Revenue by Type (2016-2027)
7.2 Europe Guanfacine Extended-Release Pill Market Size by Application
7.2.1 Europe Guanfacine Extended-Release Pill Sales by Application (2016-2027)
7.2.2 Europe Guanfacine Extended-Release Pill Revenue by Application (2016-2027)
7.3 Europe Guanfacine Extended-Release Pill Market Size by Country
7.3.1 Europe Guanfacine Extended-Release Pill Sales by Country (2016-2027)
7.3.2 Europe Guanfacine Extended-Release Pill Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Guanfacine Extended-Release Pill Market Size by Type
8.1.1 Asia Pacific Guanfacine Extended-Release Pill Sales by Type (2016-2027)
8.1.2 Asia Pacific Guanfacine Extended-Release Pill Revenue by Type (2016-2027)
8.2 Asia Pacific Guanfacine Extended-Release Pill Market Size by Application
8.2.1 Asia Pacific Guanfacine Extended-Release Pill Sales by Application (2016-2027)
8.2.2 Asia Pacific Guanfacine Extended-Release Pill Revenue by Application (2016-2027)
8.3 Asia Pacific Guanfacine Extended-Release Pill Market Size by Region
8.3.1 Asia Pacific Guanfacine Extended-Release Pill Sales by Region (2016-2027)
8.3.2 Asia Pacific Guanfacine Extended-Release Pill Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Guanfacine Extended-Release Pill Market Size by Type
9.1.1 Latin America Guanfacine Extended-Release Pill Sales by Type (2016-2027)
9.1.2 Latin America Guanfacine Extended-Release Pill Revenue by Type (2016-2027)
9.2 Latin America Guanfacine Extended-Release Pill Market Size by Application
9.2.1 Latin America Guanfacine Extended-Release Pill Sales by Application (2016-2027)
9.2.2 Latin America Guanfacine Extended-Release Pill Revenue by Application (2016-2027)
9.3 Latin America Guanfacine Extended-Release Pill Market Size by Country
9.3.1 Latin America Guanfacine Extended-Release Pill Sales by Country (2016-2027)
9.3.2 Latin America Guanfacine Extended-Release Pill Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Guanfacine Extended-Release Pill Market Size by Type
10.1.1 Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2016-2027)
10.1.2 Middle East and Africa Guanfacine Extended-Release Pill Revenue by Type (2016-2027)
10.2 Middle East and Africa Guanfacine Extended-Release Pill Market Size by Application
10.2.1 Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2016-2027)
10.2.2 Middle East and Africa Guanfacine Extended-Release Pill Revenue by Application (2016-2027)
10.3 Middle East and Africa Guanfacine Extended-Release Pill Market Size by Country
10.3.1 Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2016-2027)
10.3.2 Middle East and Africa Guanfacine Extended-Release Pill Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 TWi Pharmaceuticals USA, Inc.
11.1.1 TWi Pharmaceuticals USA, Inc. Corporation Information
11.1.2 TWi Pharmaceuticals USA, Inc. Overview
11.1.3 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Product Description
11.1.5 TWi Pharmaceuticals USA, Inc. Recent Developments
11.2 Shire Pharmaceuticals
11.2.1 Shire Pharmaceuticals Corporation Information
11.2.2 Shire Pharmaceuticals Overview
11.2.3 Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Shire Pharmaceuticals Guanfacine Extended-Release Pill Product Description
11.2.5 Shire Pharmaceuticals Recent Developments
11.3 APOTEX
11.3.1 APOTEX Corporation Information
11.3.2 APOTEX Overview
11.3.3 APOTEX Guanfacine Extended-Release Pill Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 APOTEX Guanfacine Extended-Release Pill Product Description
11.3.5 APOTEX Recent Developments
11.4 TEVA Generics
11.4.1 TEVA Generics Corporation Information
11.4.2 TEVA Generics Overview
11.4.3 TEVA Generics Guanfacine Extended-Release Pill Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 TEVA Generics Guanfacine Extended-Release Pill Product Description
11.4.5 TEVA Generics Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Guanfacine Extended-Release Pill Value Chain Analysis
12.2 Guanfacine Extended-Release Pill Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Guanfacine Extended-Release Pill Production Mode & Process
12.4 Guanfacine Extended-Release Pill Sales and Marketing
12.4.1 Guanfacine Extended-Release Pill Sales Channels
12.4.2 Guanfacine Extended-Release Pill Distributors
12.5 Guanfacine Extended-Release Pill Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Guanfacine Extended-Release Pill Industry Trends
13.2 Guanfacine Extended-Release Pill Market Drivers
13.3 Guanfacine Extended-Release Pill Market Challenges
13.4 Guanfacine Extended-Release Pill Market Restraints

14 Key Findings in The Global Guanfacine Extended-Release Pill Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Guanfacine Extended-Release Pill Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 1mg/Pill
Table 3. Major Manufacturers of 2mg/Pill
Table 4. Global Guanfacine Extended-Release Pill Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Guanfacine Extended-Release Pill Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Guanfacine Extended-Release Pill Sales by Region (2016-2021) & (K Units)
Table 7. Global Guanfacine Extended-Release Pill Sales Market Share by Region (2016-2021)
Table 8. Global Guanfacine Extended-Release Pill Sales by Region (2022-2027) & (K Units)
Table 9. Global Guanfacine Extended-Release Pill Sales Market Share by Region (2022-2027)
Table 10. Global Guanfacine Extended-Release Pill Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Guanfacine Extended-Release Pill Revenue Market Share by Region (2016-2021)
Table 12. Global Guanfacine Extended-Release Pill Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Guanfacine Extended-Release Pill Revenue Market Share by Region (2022-2027)
Table 14. Global Guanfacine Extended-Release Pill Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Guanfacine Extended-Release Pill Sales Share by Manufacturers (2016-2021)
Table 16. Global Guanfacine Extended-Release Pill Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Guanfacine Extended-Release Pill Revenue Share by Manufacturers (2016-2021)
Table 18. Guanfacine Extended-Release Pill Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Guanfacine Extended-Release Pill Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Guanfacine Extended-Release Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guanfacine Extended-Release Pill as of 2020)
Table 21. Guanfacine Extended-Release Pill Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Guanfacine Extended-Release Pill Product Offered
Table 23. Date of Manufacturers Enter into Guanfacine Extended-Release Pill Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 26. Global Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 27. Global Guanfacine Extended-Release Pill Sales Share by Type (2016-2021)
Table 28. Global Guanfacine Extended-Release Pill Sales Share by Type (2022-2027)
Table 29. Global Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Guanfacine Extended-Release Pill Revenue Share by Type (2016-2021)
Table 32. Global Guanfacine Extended-Release Pill Revenue Share by Type (2022-2027)
Table 33. Guanfacine Extended-Release Pill Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Guanfacine Extended-Release Pill Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 36. Global Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 37. Global Guanfacine Extended-Release Pill Sales Share by Application (2016-2021)
Table 38. Global Guanfacine Extended-Release Pill Sales Share by Application (2022-2027)
Table 39. Global Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Guanfacine Extended-Release Pill Revenue Share by Application (2016-2021)
Table 42. Global Guanfacine Extended-Release Pill Revenue Share by Application (2022-2027)
Table 43. Guanfacine Extended-Release Pill Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Guanfacine Extended-Release Pill Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 46. North America Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 47. North America Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 50. North America Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 51. North America Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Guanfacine Extended-Release Pill Sales by Country (2016-2021) & (K Units)
Table 54. North America Guanfacine Extended-Release Pill Sales by Country (2022-2027) & (K Units)
Table 55. North America Guanfacine Extended-Release Pill Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Guanfacine Extended-Release Pill Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 58. Europe Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 59. Europe Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 62. Europe Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 63. Europe Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Guanfacine Extended-Release Pill Sales by Country (2016-2021) & (K Units)
Table 66. Europe Guanfacine Extended-Release Pill Sales by Country (2022-2027) & (K Units)
Table 67. Europe Guanfacine Extended-Release Pill Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Guanfacine Extended-Release Pill Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Guanfacine Extended-Release Pill Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Guanfacine Extended-Release Pill Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Guanfacine Extended-Release Pill Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Guanfacine Extended-Release Pill Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Guanfacine Extended-Release Pill Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Guanfacine Extended-Release Pill Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Guanfacine Extended-Release Pill Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Guanfacine Extended-Release Pill Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Guanfacine Extended-Release Pill Revenue by Country (2022-2027) & (US$ Million)
Table 105. TWi Pharmaceuticals USA, Inc. Corporation Information
Table 106. TWi Pharmaceuticals USA, Inc. Description and Major Businesses
Table 107. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Product
Table 109. TWi Pharmaceuticals USA, Inc. Recent Developments
Table 110. Shire Pharmaceuticals Corporation Information
Table 111. Shire Pharmaceuticals Description and Major Businesses
Table 112. Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Shire Pharmaceuticals Guanfacine Extended-Release Pill Product
Table 114. Shire Pharmaceuticals Recent Developments
Table 115. APOTEX Corporation Information
Table 116. APOTEX Description and Major Businesses
Table 117. APOTEX Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. APOTEX Guanfacine Extended-Release Pill Product
Table 119. APOTEX Recent Developments
Table 120. TEVA Generics Corporation Information
Table 121. TEVA Generics Description and Major Businesses
Table 122. TEVA Generics Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. TEVA Generics Guanfacine Extended-Release Pill Product
Table 124. TEVA Generics Recent Developments
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Guanfacine Extended-Release Pill Distributors List
Table 128. Guanfacine Extended-Release Pill Customers List
Table 129. Guanfacine Extended-Release Pill Market Trends
Table 130. Guanfacine Extended-Release Pill Market Drivers
Table 131. Guanfacine Extended-Release Pill Market Challenges
Table 132. Guanfacine Extended-Release Pill Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Guanfacine Extended-Release Pill Product Picture
Figure 2. Global Guanfacine Extended-Release Pill Market Share by Type in 2020 & 2027
Figure 3. 1mg/Pill Product Picture
Figure 4. 2mg/Pill Product Picture
Figure 5. Global Guanfacine Extended-Release Pill Market Share by Application in 2020 & 2027
Figure 6. Inattention in Children
Figure 7. Children's Emotional Impulse
Figure 8. Guanfacine Extended-Release Pill Report Years Considered
Figure 9. Global Guanfacine Extended-Release Pill Sales 2016-2027 (K Units)
Figure 10. Global Guanfacine Extended-Release Pill Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Guanfacine Extended-Release Pill Revenue 2016-2027 (US$ Million)
Figure 12. Global Guanfacine Extended-Release Pill Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Guanfacine Extended-Release Pill Sales Market Share by Region (2016-2021)
Figure 14. Global Guanfacine Extended-Release Pill Sales Market Share by Region (2022-2027)
Figure 15. North America Guanfacine Extended-Release Pill Sales YoY (2016-2027) & (K Units)
Figure 16. North America Guanfacine Extended-Release Pill Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Guanfacine Extended-Release Pill Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Guanfacine Extended-Release Pill Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Guanfacine Extended-Release Pill Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Guanfacine Extended-Release Pill Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Guanfacine Extended-Release Pill Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Guanfacine Extended-Release Pill Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Guanfacine Extended-Release Pill Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Guanfacine Extended-Release Pill Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Guanfacine Extended-Release Pill Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Guanfacine Extended-Release Pill Revenue in 2020
Figure 27. Guanfacine Extended-Release Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 29. Global Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 30. Global Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 31. Global Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 32. North America Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 33. North America Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 34. North America Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 35. North America Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 36. North America Guanfacine Extended-Release Pill Sales Share by Country (2016-2027)
Figure 37. North America Guanfacine Extended-Release Pill Revenue Share by Country (2016-2027)
Figure 38. United States Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 41. Europe Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 42. Europe Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 43. Europe Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 44. Europe Guanfacine Extended-Release Pill Sales Share by Country (2016-2027)
Figure 45. Europe Guanfacine Extended-Release Pill Revenue Share by Country (2016-2027)
Figure 46. Germany Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 47. France Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Guanfacine Extended-Release Pill Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Guanfacine Extended-Release Pill Revenue Share by Region (2016-2027)
Figure 57. China Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 60. India Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 67. Latin America Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 69. Latin America Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Guanfacine Extended-Release Pill Sales Share by Country (2016-2027)
Figure 71. Latin America Guanfacine Extended-Release Pill Revenue Share by Country (2016-2027)
Figure 72. Mexico Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 75. Colombia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Guanfacine Extended-Release Pill Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Guanfacine Extended-Release Pill Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Guanfacine Extended-Release Pill Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Guanfacine Extended-Release Pill Revenue Share by Country (2016-2027)
Figure 82. Turkey Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Guanfacine Extended-Release Pill Revenue (2016-2027) & (US$ Million)
Figure 85. Guanfacine Extended-Release Pill Value Chain
Figure 86. Guanfacine Extended-Release Pill Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---